2022 ku post san antonio review | early-stage hormone breast cancer: optimizing systemic therapy
Published 2 years ago • 1.4K plays • Length 31:32Download video MP4
Download video MP3
Similar videos
-
28:05
2022 ku post san antonio review | breast cancer risk assessment and reduction: what's new
-
24:34
2022 ku post san antonio review | updates in locoregional therapy
-
30:10
2022 ku post san antonio review | metastatic her2 positive breast cancer: novel treatment approaches
-
46:12
2022 ku post san antonio review | monday morning practice implications: q&a and case discussion 1
-
23:20
2022 ku post san antonio review | (neo)adjuvant therapy for triple negative breast cancer
-
46:00
2022 ku post san antonio review | monday morning practice implications: q&a and case discussion 2
-
28:02
2022 west oncology conference | breast cancers | early-stage
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan
-
41:53
guideline updates for extended endocrine therapy decision-making in hr , early-stage breast cancer
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
52:21
new & supporting data for optimizing therapy in her2 breast cancer | dr. irene and dr. vogel
-
42:02
asco breast cancer update | jane meisel, md | 2022 review and renew sedona
-
2:56
on the role of molecular tumor profiling in breast cancer: 2023 ku breast cancer year in review
-
1:25
breast cancer molecular testing – more tools in the toolbox: 2023 ku breast cancer year in review
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
1:10:36
updates in extended endocrine therapy for hr breast cancer | asco21 & national practice guidelines
-
53:42
guideline updates for extended endocrine therapy decision-making in hr , early-stage breast cancer
-
1:28:08
2021 sabcs what changes monday morning? triple-negative breast cancer panel discussion